nach oben

Current Hypertension Reports

Erschienen in:

01.08.2016 | Novel Treatments for Hypertension (T Unger, Section Editor)

Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update

verfasst von: Renata Cifkova, George Fodor, Peter Wohlfahrt

Erschienen in: Current Hypertension Reports | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of this paper was to critically evaluate recent publications on hypertension treatment and control in regions by income. Prevalence of hypertension is increasing worldwide, most prominently in low-income countries. Awareness, treatment, and control are most successful in North America while remaining a challenge in middle- and low-income countries. Easy access to medical care and aggressive use of pharmacotherapy are the key strategies which have proved to be successful in reducing the burden of hypertension on the population level.

http://www.who.int/mediacentre/factsheets/fs317/en/accessed 18.04.2016.

Chobanian AV. Shattuck Lecture. The hypertension paradox—more uncontrolled disease despite improved therapy. N Engl J Med. 2009;361(9):878–87. doi:10.1056/NEJMsa0903829.CrossRefPubMed

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.CrossRefPubMed

4.••

Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2(8):634–47. doi:10.1016/S2213-8587(14)70102-0. CVD, CKD, and diabetes mortality attributable to elevated BP and glucose serum cholesterol, and BMI were estimated. CrossRef

Wilber JA, Barrow JG. Hypertension—a community problem. Am J Med. 1972;52(5):653–63.CrossRefPubMed

Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43(1):10–7.CrossRefPubMed

Yoon SS, Fryar CD, Carroll MD. Hypertension prevalence and control among adults: United States, 2011–2014. U.S. National Center Health Statistics, Data Brief No. 220, 8 pp. (PHS) 2016-1209. November 2015.

Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Moy Lum-Kwong M, Fodor G. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008 20;178(11):1441–9. doi: 10.1503/cmaj.071340.

McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183(9):1007–13. doi:10.1503/cmaj.101767.CrossRefPubMed

10.

Myers MG, McInnis NH, Fodor GJ, Leenen FH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens. 2008;21(3):280–3. doi:10.1038/ajh.2007.54.CrossRefPubMed

11.

Törmä E, Carlberg B, Eriksson M, Jansson JH, Eliasson M. Long term trends in control of hypertension in the Northern Sweden MONICA study 1986-2009. BMC Public Health. 2015;15:957. doi:10.1186/s12889-015-2280-6.CrossRefPubMedPubMedCentral

12.

Rückert IM, Baumert J, Schunk M, Holle R, Schipf S, Völzke H, et al. Blood pressure control has improved in people with and without type 2 diabetes but remains suboptimal: a longitudinal study based on the German DIAB-CORE consortium. PLoS One. 2015;10(7):e0133493. doi:10.1371/journal.pone.0133493. eCollection 2015.CrossRefPubMedPubMedCentral

13.

Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–11. J Hum Hypertens. 2015;29(4):247–53. doi:10.1038/jhh.2014.82.CrossRefPubMed

14.

Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. PHYSA study J Hypertens. 2014;32(6):1211–21. doi:10.1097/HJH.0000000000000162.CrossRefPubMed

15.

Reklaitiene R, Tamosiunas A, Virviciute D, Baceviciene M, Luksiene D. Trends in prevalence, awareness, treatment, and control of hypertension, and the risk of mortality among middle-aged Lithuanian urban population in 1983–2009. BMC Cardiovasc Disord. 2012;12:68. doi:10.1186/1471-2261-12-68.CrossRefPubMedPubMedCentral

16.

Dorobanţu M, Darabont R, Ghiorghe S, Arsenescu-Georgescu C, Macarie C, Mitu F, et al. Hypertension prevalence and control in Romania at a seven-year interval. Comparison of SEPHAR I and II surveys. J Hypertens. 2014;32(1):39–47. doi:10.1097/01.hjh.0000434937.62412.24.CrossRefPubMed

17.

Lovic D, Stojanov V, Jakovljević B, Krotin M, Jurisic V, Djordjevic D, et al. Prevalence of arterial hypertension in Serbia: PAHIS study. J Hypertens. 2013;31(11):2151–7. doi:10.1097/HJH.0b013e328364c2a2. discussion 2157.CrossRefPubMed

18.

Liao Y, Gilmour S, Shibuya K. Health insurance coverage and hypertension control in China: results from the China Health and Nutrition Survey. PLoS One. 2016;11(3):e0152091. doi:10.1371/journal.pone.0152091. eCollection 2016.CrossRefPubMedPubMedCentral

19.

Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, Karatan O, Turgan C, Hasanoglu E, Caglar S, Erturk S; Turkish Society of Hypertension and Renal Diseases. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens 2016 Mar 17. [Epub ahead of print]

20.•

Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170–7. doi:10.1097/HJH.0000000000000146. A systematic review of epidemiology of hypertension in India from 1950 to 2013. CrossRefPubMedPubMedCentral

21.

Jin C-N, Yu C-M, Sun J-P, Fang F, Wen Y-N, Liu M, et al. The healthcare burden of hypertension in Asia. Heart Asia. 2013;5:238–43.CrossRefPubMedPubMedCentral

22.•

Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013;62(1):18–26. doi:10.1161/HYPERTENSIONAHA.113.01374. Identification of socio-demographic predictors of hypertension prevalence, diagnosis, treatment, and control in 6 middle-income countries. CrossRefPubMed

23.•

Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2015;65(2):291–8. doi:10.1161/HYPERTENSIONAHA.114.04394. A systematic review of hypertension studies in sub-Saharan Africa between 2000 and 2013. CrossRefPubMed

24.

Bosu WK. The prevalence, awareness, and control of hypertension among workers in West Africa: a systematic review. Glob Health Action. 2015;8:26227. doi:10.3402/gha.v8.26227. eCollection 2015.PubMed

25.

Neupane D, McLachlan CS, Sharma R, Gyawali B, Khanal V, Mishra SR, et al. Prevalence of hypertension in member countries of South Asian Association for Regional Cooperation (SAARC): systematic review and meta-analysis. Medicine (Baltimore). 2014;93(13):e74. doi:10.1097/MD.0000000000000074.CrossRef

26.

Redón J, Cea-Calvo L, Lozano JV, Martí-Canales JC, Llisterri JL, Aznar J. González-Esteban J; on behalf of the investigators of the PREV-ICTUS Study. Differences in blood pressure control and stroke mortality across Spain. The Prevención de Riesgo de Ictus (PREV-ICTUS) Study. Hypertension. 2007;49(4):799–805.CrossRefPubMed

27.

Cooper RS. Using public health indicators to measure the success of hypertension control. Hypertension 2007;49(4):773–4. Epub 2007 Feb 19. No abstract available.

28.

Redon J, Olsen MH, Cooper RS, Zurriaga O, Martinez-Beneito MA, Laurent S, et al. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J. 2011;32(11):1424–31. doi:10.1093/eurheartj/ehr045.CrossRefPubMed

29.••

Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383(9913):245–54. Review. Erratum in: Lancet 2014;383(9913):218. This study is the first to report the global burden of stroke (incidence, prevalence, mortality, DALYs lost, and mortality-to-incidence ratios).

30.

Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52(5):818–27. doi:10.1161/HYPERTENSIONAHA.108.113357.CrossRefPubMed

31.

http://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf; accessed 22.04.2016.

32.

O'Donnell M, Mente A, Yusuf S. Commentary: accepting what we don't know will lead to progress. Int J Epidemiol. 2016;45(1):260–2. doi:10.1093/ije/dyw014.CrossRefPubMed

33.

Webster JL, Dunford EK, Hawkes C, Neal BC. Salt reduction initiatives around the world. J Hypertens. 2011;29(6):1043–50. doi:10.1097/HJH.0b013e328345ed83.CrossRefPubMed

34.

Semlitsch T, Jeitler K, Berghold A, Horvath K, Posch N, Poggenburg S, Siebenhofer A. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No.: CD008274. DOI:10.1002/14651858.CD008274.pub3.

35.

Cutler DM, Long G, Berndt ER, Royer J, Fournier AA, Sasser A, et al. The value of antihypertensive drugs: a perspective on medical innovation. Health Aff (Millwood). 2007;26(1):97–110.CrossRef

36.

Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015;116(6):1074–95. doi:10.1161/CIRCRESAHA.116.303603.CrossRefPubMed

Titel: Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update
verfasst von: Renata Cifkova
George Fodor
Peter Wohlfahrt
Publikationsdatum: 01.08.2016
Verlag: Springer US
Erschienen in: Current Hypertension Reports / Ausgabe 8/2016
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-016-0669-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Device-based Therapy for Hypertension

Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension

Device-Based Therapy for Drug-Resistant Hypertension: An Update

Left Ventricular Hypertrophy in Children with Hypertension: in Search of a Definition

Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights

Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials